A2 BiotherapeuticsA2 Biotherapeutics

News

  • News
  • Media Inquiries

November 7, 2022

A2 Bio Identifying Solid Tumor Patients for Possible Inclusion in Phase 1 Studies Targeting CEA and Mesothelin Expected to Begin in 2023: Update at SITC 2022

 

March 4, 2022

FierceBiotech
A2 Bio’s Activator-blocker CAR-T Cell Therapies Show Early Promise in Solid Cancers

 

March 2, 2022

A2 Bio Publishes Key Preclinical Findings Demonstrating Potential of Its Highly Selective Tmod™ Cell Therapy Platform to Revolutionize the Treatment of Solid Tumors in Select Patients

 

January 18, 2022

A2 Bio to Present at ASCO-GI 2022 on Use of Next Generation Sequencing (NGS) to Identify GI Cancer Patients for Future TmodTM CAR T Therapy

 

November 12, 2021

A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021

 

November 1, 2021

A2 Bio to Highlight Program Updates in Two Presentations at SITC 2021

 

January 13, 2021

Tempus Announces Companion Diagnostic Collaboration with A2 Biotherapeutics

 

December 23, 2020

A2 Biotherapeutics Enters into Collaboration Agreement with Merck to Develop Allogeneic Cell Therapy for Solid Tumor Cancers

 

October 6, 2020

A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical Development of its Potentially Transformative Selective Tumor Cell Therapeutics

 

November 5, 2019

A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics

Contact Our Media Team
  • Science
    • Overview
    • Technology Platform
    • Manufacturing
    • Publications
  • Pipeline
    • Overview
  • Clinical Trials
    • Overview
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Partners
  • Newsroom
    • News
    • Media Inquiries
  • Careers
    • Join the Team
  • Contact
    • General Inquiries
A2 Bio Logo White

30301 Agoura Road #210
Agoura Hills, CA 91301


[email protected]

© Copyright 2022. All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Social Media
  • Cookies
  • California Compliance
  • Science
    • Overview
    • Technology Platform
    • Manufacturing
    • Publications
  • Pipeline
    • Overview
  • Clinical Trials
    • Overview
  • About Us
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Partners
  • Investors
    • Overview
  • Newsroom
    • News
    • Media Inquiries
  • Careers
    • Join the Team
  • Contact
    • General Inquires